Partner with Experts in Precision Medicine

A global CRO to help you navigate the complexities of drug development and improve health for all.

More details
Partner with Experts in Precision Medicine
Advancing Biomarker Strategies

Providing high-end scientific capabilities, multiple platforms, and regulatory expertise to support all phases of therapeutic development.

Learn More
Advancing Biomarker Strategies
We Understand the Value of Your Samples

Integrated sample management, logistics, and kitting solutions with unique expertise in handling specialty samples.

Learn More
We Understand the Value of Your Samples
CellCarta Acquires Biogazelle

Expanding our genomic biomarker franchise with the acquisition of Biogazelle, an expert in dPCR, qPCR, and RNAseq assays.

More details
CellCarta Acquires Biogazelle
Testing Services
Technologies
Therapeutic Areas
Logistic Services

Latest News and Events

CellCarta Logo

News

CellCarta expands it proteomics portfolio with the acquisition of next-generation immuno-MRM assays from Precision Assays

May 19, 2022

More info

News

physIQ and CellCarta Collaborate to Accelerate a More Precise, Personalized Approach to Vaccine Development

March 17, 2022

More info
Biogazelle

News

CellCarta acquires Biogazelle

December 14, 2021

More info
Reveal_PR

News

CellCarta acquires Reveal Biosciences

May 11, 2021

More info
Services
CellEngine® Software

Cytometry analysis that is faster, more reliable with advanced visualization features

More info
CellEngine® Software
Services
MOSAIC Laboratories – A CellCarta Company

Pioneer in histopathology and multiplex IHC (mIHC) assays

More info
MOSAIC Laboratories – A CellCarta Company
Technology
Olink® PEA Technology

CellCarta offers Olink® Target 96 & Target 48 panels for advanced protein biomarker quantification

More info
Olink® PEA Technology
Therapeutic Area
Oncology

Developing and deploying assays for exploratory, secondary, and primary endpoints to support multitude of oncology programs.

More info
Oncology

Science Hub

Infographics

Antisense Oligonucleotide (ASO) Screening Platform

June 23, 2022

More info

CellTalk

Landmark study on metastatic breast cancer highlights the importance of identifying HER2-low patients

June 23, 2022

Proteomics/Mass Spectrometry

More info

Webinars

Applications of Digital PCR in Clinical Research

June 1, 2022

More info

Press Releases

CellCarta expands it proteomics portfolio with the acquisition of next-generation immuno-MRM assays from Precision Assays

May 19, 2022

Proteomics/Mass Spectrometry

More info

Careers

The best scientific minds working together to advance precision medicine

If you are passionate about science, join CellCarta and help shape the future of precision medicine.

See our job opportunities
Brandbourg_Caprion-1335-v2